Related Experiment Video
Updated: May 23, 2026

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Ketamine for chronic noncancer pain: concerns regarding toxicity
1Multidisciplinary Pain Clinic/Regional Centre of Excellence in Palliative Care, Haukeland University Hospital, Bergen, Norway. rae.bell@helse-bergen.no
Purpose Of Review:
Ketamine misuse and abuse is on the increase. This review focuses on recent studies on ketamine toxicity in recreational users and possible implications for the use of ketamine in chronic pain therapy.
Recent Findings:
Urological toxicity, hepatotoxicity and cognitive deficits are all reported as adverse effects of the recreational use of ketamine. Urological toxicity and hepatotoxicity have been reported as adverse effects of ketamine in pain therapy.
Summary:
These findings may have implications for the clinical use of ketamine in chronic noncancer pain conditions. Until safety issues are resolved, it is suggested that chronic pain treatment involving higher doses and repeated exposure to ketamine be restricted to the context of randomized, controlled trials or clinical audits.
Related Concept Videos
Parenteral Anesthetics: Overview
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Drug Toxicity: Dose-Dependent Reactions
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Analgesia and Pain Management
Drug Toxicity: Overview